Targeting colorectal cancer with anti-epidermal growth factor receptor antibodies: focus on panitumumab

The tumor biology targeted therapies have improved outcomes in colorectal cancer (CRC). The epidermal growth factor receptor (EGFR) inhibitors represent one of these successful strategies. EGFR is frequently overexpressed in CRCs and associated with a malignant phenotype. Two EGFR inhibitors have sh...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Kerry J, Lockhart, A Craig
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886332/
https://www.ncbi.nlm.nih.gov/pubmed/20616903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886332/
https://www.ncbi.nlm.nih.gov/pubmed/20616903

Ejemplares similares